14983981|t|NC-531 (Neurochem).
14983981|a|NC-531 is a sulfated glycosaminoglycan mimetic that inhibits amyloid plaque formation, and is under development by Neurochem for the potential treatment of Alzheimer's disease. Phase I clinical trials of NC-531 were ongoing in November 1999, and by October 2002 phase II trials were underway.
14983981	0	6	NC-531	Chemical	MESH:C486237
14983981	20	26	NC-531	Chemical	MESH:C486237
14983981	32	58	sulfated glycosaminoglycan	Chemical	MESH:C013786
14983981	81	88	amyloid	Disease	MESH:C000718787
14983981	176	195	Alzheimer's disease	Disease	MESH:D000544
14983981	224	230	NC-531	Chemical	MESH:C486237
14983981	Negative_Correlation	MESH:C013786	MESH:C000718787
14983981	Negative_Correlation	MESH:C486237	MESH:C000718787
14983981	Negative_Correlation	MESH:C486237	MESH:D000544

